Aug 27, 2026 08:01AM
Aug 27, 2026 08:00AM
Aug 6, 2026 08:09AM
Aug 6, 2026 08:00AM
Jul 15, 2026 08:30AM
Jul 15, 2026 08:30AM
May 7, 2026 08:33AM MBX (MBX) Reports Q1 Loss of $0.51
May 7, 2026 08:00AM
Mar 12, 2026 04:01PM
Mar 12, 2026 04:00PM
Mar 12, 2026 03:56PM
Mar 12, 2026 08:00AM
Mar 9, 2026 10:21AM
Mar 9, 2026 10:21AM CORRECTING & REPLACING -- MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Mar 9, 2026 08:01AM
Mar 9, 2026 08:00AM
Jan 22, 2026 08:00AM
Jan 22, 2026 08:00AM
Jan 11, 2026 04:00PM
Dec 18, 2025 07:46AM
Dec 11, 2025 05:00PM Microbix Schedules Release of Results for Q4 Fiscal 2025
Dec 10, 2025 07:00AM
Dec 4, 2025 07:00AM
Dec 3, 2025 07:00AM
Nov 12, 2025 07:00AM
Nov 6, 2025 04:32PM
Nov 6, 2025 08:00AM
Nov 5, 2025 07:00AM Microbix Addresses Cybersecurity Incident
Oct 8, 2025 07:00AM
Sep 25, 2025 07:00AM
Sep 23, 2025 07:00AM
Sep 17, 2025 07:00AM
Sep 3, 2025 01:07PM
Aug 14, 2025 07:00AM
Aug 7, 2025 08:00AM MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
Aug 7, 2025 07:00AM
Jul 29, 2025 07:00AM
Jul 24, 2025 07:00AM
Jul 8, 2025 07:00AM
Jun 17, 2025 07:00AM
May 15, 2025 07:16AM
May 13, 2025 07:00AM Microbix & Aurevia Introduce Novel EQA Scheme
May 13, 2025 06:30AM
May 12, 2025 08:00AM
May 8, 2025 07:00AM
May 5, 2025 07:00AM
May 1, 2025 07:00AM
Apr 9, 2025 07:00AM
Apr 8, 2025 07:00AM Microbix Provides Business Updates
Mar 27, 2025 07:00AM

1,222,617 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All